AATM Inhibitors

AATM inhibitors encompass a diverse range of chemicals that can modulate the activity of the AATM protein through various indirect mechanisms. These compounds interact with different cellular processes and pathways that are connected to the function of AATM, although they do not directly target the protein itself. The chemical inhibitors listed include antioxidants, metabolic regulators, autophagy modulators, and kinase inhibitors, each with a distinct mode of action that can ultimately influence the activity of AATM.

The inhibitors range from small organic molecules, such as N-Acetylcysteine and Dichloroacetate, which can affect the redox state of the cell and metabolic pathways, to more targeted kinase inhibitors like Wortmannin and LY294002, which disrupt specific signaling cascades. Autophagy inhibitors like Chloroquine and 3-Methyladenine can impact the turnover and recycling of cellular components, which is a process that AATM is involved in. Furthermore, compounds such as Metformin and Resveratrol can modulate the activity of enzymes like AMPK and SIRT1, respectively, leading to secondary effects on AATM-related pathways. These chemicals operate within the complex cellular network and can alter the balance of signaling pathways, protein interactions, and cellular states that relate to the function of AATM. Each inhibitor's unique chemical structure and specific biochemical interactions contribute to its ability to modulate the AATM protein's role within the cell.